Abbott 4Q flat, diet and bipolar drug sales down - Chicago Tribune
|
Abbott 4Q flat, diet and bipolar drug sales down
Chicago Tribune Abbott also said its drug sales were hurt by the suspension of sales in certain markets of the diet drug Meridia, which has for years faced criticism from … Abbott Labs 4Q Profit Edges Upward, Sales Jump 11% |
More: continued here
